Josh Disbrow — SPARQNOW

At-a-Glance

Co-Founder, Chief Executive Officer, & Board Director at Aytu BioPharma (Nasdaq: AYTU)
Co-founded Aytu BioPharma in 2015, growing revenue from $0 to over $100M
Led Aytu BioPharma's initial public listing on Nasdaq in October 2017
Led strategic transactions valued at over $200M, including multiple company acquisitions and product licensing deals
Holds a Master of Business Administration and a Bachelor of Science in Management

Biography

Josh Disbrow is the Co-Founder, Chief Executive Officer, and Board Director of Aytu BioPharma, a patient-centric pharmaceutical company. He co-founded the company in 2015 and has since led its growth, including initial capital formation, building out the board and management team, and executing licensing and product acquisitions. Under his leadership, Aytu BioPharma has grown its revenue from $0 to over $100 million through organic and inorganic growth strategies.